265 related articles for article (PubMed ID: 36111408)
21. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
Spoerl D; Bircher AJ; Scherer K
J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
[TBL] [Abstract][Full Text] [Related]
22. Safety and Effectiveness of a 3-Day Rush Insect Venom Immunotherapy Protocol.
Kranert P; Forchhammer S; Volc S; Stenger F; Schaller M; Fischer J
Int Arch Allergy Immunol; 2020; 181(2):111-118. PubMed ID: 31794966
[TBL] [Abstract][Full Text] [Related]
23. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
van der Brempt X; Ledent C; Mairesse M
Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
[TBL] [Abstract][Full Text] [Related]
24. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
[TBL] [Abstract][Full Text] [Related]
25. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
Ruëff F; Przybilla B
J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
[No Abstract] [Full Text] [Related]
26. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
Ruëff F; Bauer A; Becker S; Brehler R; Brockow K; Chaker AM; Darsow U; Fischer J; Fuchs T; Gerstlauer M; Gernert S; Hamelmann E; Hötzenecker W; Klimek L; Lange L; Merk H; Mülleneisen NK; Neustädter I; Pfützner W; Sieber W; Sitter H; Skudlik C; Treudler R; Wedi B; Wöhrl S; Worm M; Jakob T
Allergol Select; 2023; 7():154-190. PubMed ID: 37854067
[TBL] [Abstract][Full Text] [Related]
28. Field sting reactions in patients receiving Hymenoptera venom immunotherapy: real-life experience.
Sözener ZÇ; Kendirlinan R; Çerçi P; Ayd N Ö; Mungan D; Bavbek S; Demirel Y; Mısırl Gil Z; Sin BA
Asian Pac J Allergy Immunol; 2023 Sep; 41(3):186-192. PubMed ID: 35278056
[TBL] [Abstract][Full Text] [Related]
29. [Venom immunotherapy. Side effects and efficacy of treatment].
Ruëff F; Przybilla B
Hautarzt; 2008 Mar; 59(3):200-5. PubMed ID: 18264687
[TBL] [Abstract][Full Text] [Related]
30. [Wasp and bee venom allergy].
Knulst AC; de Maat-Bleeker F; Bruijnzeel-Koomen CA
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):889-92. PubMed ID: 9623183
[TBL] [Abstract][Full Text] [Related]
31. Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Seitz MJ; Aberer W; Bodzenta-Lukaszyk A; Bonifazi F; Campi P; Darsow U; Haeberli G; Hawranek T; Küchenhoff H; Lang R; Quercia O; Reider N; Schmid-Grendelmeier P; Severino M; Sturm GJ; Treudler R; Wüthrich B
PLoS One; 2013; 8(5):e63233. PubMed ID: 23700415
[TBL] [Abstract][Full Text] [Related]
32. Hymenoptera venom allergy in humans.
Cichocka-Jarosz E
Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
[TBL] [Abstract][Full Text] [Related]
33. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT.
Çetin GP; Yılmaz İ; Türk M; Arslan B; Bahçecioğlu SN
Turk J Med Sci; 2022 Aug; 52(4):1223-1234. PubMed ID: 36326412
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
Müller U; Helbling A; Berchtold E
J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
[TBL] [Abstract][Full Text] [Related]
35. Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts.
Brunetto S; Gammeri L; Buta F; Gangemi S; Ricciardi L
Allergy Asthma Proc; 2024 May; 45(3):195-200. PubMed ID: 38755779
[No Abstract] [Full Text] [Related]
36. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
Gawlik R; Glück J; Jawor B; Rogala B
Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan.
Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126
[TBL] [Abstract][Full Text] [Related]
38. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
[TBL] [Abstract][Full Text] [Related]
39. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors.
Birnbaum J; Ramadour M; Magnan A; Vervloet D
Clin Exp Allergy; 2003 Jan; 33(1):58-64. PubMed ID: 12534550
[TBL] [Abstract][Full Text] [Related]
40. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
